Skip to main content
. 2024 Jun 17;24:282. doi: 10.1186/s12890-024-03100-y

Fig. 1.

Fig. 1

(A) Difference in exacerbation frequency between the CB and non-CB groups according to CB definition; (B) Difference in severe exacerbation risk between the CB and non-CB groups according to CB definition. Age, sex, smoking status, baseline post-bronchodilator FEV1 (%) and history of exacerbation were adjusted in all analysis